This subtopic examines the entire drug development lifecycle from discovery through to large-scale production, emphasising formulation science, analytical
Topic Synopsis
This subtopic examines the entire drug development lifecycle from discovery through to large-scale production, emphasising formulation science, analytical testing, and the manufacturing of biopharmaceuticals. Students will integrate scientific principles with regulatory requirements to ensure safe, effective, and scalable medicinal products.
Key Concepts & Core Principles
- Cell structure and function: Understand the differences between prokaryotic and eukaryotic cells, and the roles of organelles like mitochondria, ribosomes, and the nucleus.
- Atomic structure and bonding: Know the arrangement of protons, neutrons, and electrons, and how ionic, covalent, and metallic bonds form.
- Newton's laws of motion: Apply the three laws to predict the motion of objects, including calculations of force, mass, and acceleration.
- Thermodynamics: Grasp the first and second laws, including concepts of energy conservation, entropy, and heat transfer.
- Practical laboratory skills: Master safe use of equipment like balances, pipettes, and microscopes, and techniques such as titration and chromatography.
Exam Tips & Revision Strategies
- When discussing the drug development process, always link each stage to its purpose and regulatory oversight (e.g., MHRA, EMA).
- For formulation questions, provide specific examples of excipients and their functions, and relate them to the route of administration.
- In production scenarios, differentiate between small molecule and biologic manufacturing, highlighting critical differences like cell culture conditions and purification steps.
Common Misconceptions & Mistakes to Avoid
- Confusing the stages of clinical trials (Phase I-III) with the overall drug development process, neglecting pre-clinical and post-marketing surveillance.
- Assuming that formulation is merely mixing active ingredients with excipients, rather than a scientific process designed to optimise delivery and stability.
- Overlooking the regulatory requirements for biopharmaceutical production, such as the need for aseptic processing and viral clearance validation.
Examiner Marking Points
- Award credit for demonstrating a clear understanding of the phases of drug development (pre-clinical to Phase IV) and how each phase contributes to product safety and efficacy.
- Expect evidence of evaluating different formulation strategies (e.g., immediate vs. modified release) and their impact on bioavailability and patient compliance.
- Look for detailed explanation of at least two assay types (e.g., HPLC for purity, ELISA for potency) and their role in quality control during development and production.